
Helicobacter Pylori Antibodies Panel IgA, IgG & IgM









The Helicobacter Pylori Antibodies Panel IgA, IgG & IgM helps detect immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) antibodies in the blood, helping to diagnose infections caused by Helicobacter Pylori, a bacteria that primarily causes gastrointestinal infections. This test helps assess the body’s immune response against this bacteria.













Understanding Helicobacter Pylori Antibodies Panel IgA, IgG & IgM
Helicobacter Pylori infection is one of the most common bacterial infections affecting both children and adults associated with a wide range of gastrointestinal conditions, including gastritis, peptic ulcers, gastric ulcers, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric adenocarcinoma. Despite its prevalence, H. pylori infection often remains asymptomatic or presents with nonspecific symptoms, making diagnosis challenging without specific laboratory testing.
The Helicobacter Pylori Antibodies Panel IgA, IgG & IgM helps detect three types of antibodies-Immunoglobulin A (IgA), Immunoglobulin G (IgG), and Immunoglobulin M (IgM) against H.pylori infection. IgA is the predominant antibody found in mucosal secretions, including those of the gastrointestinal tract. Elevated levels of IgA antibodies against H pylori may indicate an active or recent infection. IgG is the most abundant antibody in the blood and remains elevated even after the acute phase of infection has resolved, serving as a useful indicator for detecting past exposure to H. pylori IgA and IgG type of antibodies may remain high for many years in infected individuals. IgM antibodies are the first antibodies produced by the immune system during the early stages of infection, indicating acute or recent H.pylori infection.
The Helicobacter Pylori Antibodies Panel IgA, IgG & IgM is particularly valuable for individuals with gastrointestinal symptoms such as abdominal pain, bloating, nausea, and vomiting, as well as those with a history of peptic ulcers or gastric cancer. This test helps in the early detection, effective management, and ongoing monitoring of infection status.
The Helicobacter Pylori Antibodies Panel IgA, IgG & IgM is a screening test and only detects the presence of antibodies against H.pylori bacteria. It does not confirm the presence of gastrointestinal disease and therefore, should not be used as a sole criteria for the diagnosis of H. pylori-associated gastrointestinal infections. Doctors may recommend a few other tests in conjunction with the Helicobacter Pylori Antibodies Panel IgA, IgG & IgM to confirm the diagnosis.
No special preparation is needed for undertaking the Helicobacter Pylori Antibodies Panel IgA, IgG & IgM. However, it is important to inform your doctor about any medications, supplements, or medical conditions before the test as these factors may potentially influence the test results.
Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation; therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results. The insights from this test help the doctor tailor an appropriate treatment plan. Although maintaining good hygiene by washing hands thoroughly, eating hygienically prepared food, and drinking water from a safe, clean source are some ways to prevent an H. pylori infection, particularly in children.
What does Helicobacter Pylori Antibodies Panel IgA, IgG & IgM measure?
Contains 3 testsThe Helicobacter Pylori Antibodies Panel IgA, IgG & IgM measures the levels of specific antibodies, namely, Immunoglobulin A (IgA), Immunoglobulin G (IgG), and Immunoglobulin M (IgM) that are produced by the immune system in response to Helicobacter pylori (H. pylori) infection. H.pylori is a bacterium that can colonize the stomach lining and is associated with various gastrointestinal conditions, including gastritis, peptic ulcers, and gastric cancer. By detecting these antibodies, this test provides insights into the body’s immune response to H. pylori and helps doctors diagnose current or past infections. Elevated levels of IgA, IgG, and IgM antibodies may indicate the presence of an active or recent H. pylori infection, while specific antibody profiles can help differentiate between acute and chronic infections.
The Helicobacter Pylori Antibodies Panel IgA, IgG & IgM tells about gastrointestinal health. The test results can help individuals and doctors understand the risk of H.pylori-related conditions, such as peptic ulcers or gastric cancer, and guide treatment decisions if infection is detected. Additionally, this test helps monitor changes in antibody levels over time and can assess the effectiveness of the treatment regimen. The Helicobacter Pylori Antibodies Panel IgA, IgG & IgM empowers individuals to take proactive steps in managing their gastrointestinal health and minimizing the risk of associated complications.
The Helicobacter Pylori, IgM test detects the presence of immunoglobulin M (IgM) antibodies produced by the immune system in response to Helicobacter pylori (H. pylori) infection. H.pylori is a bacterium that can colonize in the stomach lining and is associated with various gastrointestinal conditions, including gastritis, peptic ulcers, and gastric cancer.
By detecting IgM antibodies, this test helps doctors diagnose current H. pylori infection as these are the first antibodies to appear as an immediate response to an infection and typically become undetectable after some time. Therefore, the presence of IgM antibodies in the blood signals an active/ongoing H. pylori infection.
The test results can help individuals and doctors understand the risk of H.pylori-related conditions, such as peptic ulcers or gastric cancer, and guide treatment decisions if infection is detected. This test also helps monitor treatment response over time and allows infected individuals to take proactive steps in managing their gastrointestinal health and reducing the risk of complications.
Know more about Helicobacter Pylori, IgM
The Helicobacter Pylori, IgG test detects the presence of IgG antibodies in the blood. These antibodies appear a few weeks after infection and stay for months or even years. Their presence shows past exposure to H. pylori.
Getting tested can help understand the risk of H.pylori-related conditions, such as peptic ulcers or gastric cancer. It also helps monitor treatment response over time, allowing infected individuals to take proactive steps against H.Pylori infection and thus reducing the risk of complications.
Know more about Helicobacter Pylori, IgG





FAQs related to Helicobacter Pylori Antibodies Panel IgA, IgG & IgM
- Helicobacter Pylori Antibody [Internet]. Rochester, NY: University of Rochester Medical Center; [Accessed 26 Mar. 2024]. Available from:
- Parikh NS, Ahlawat R. Helicobacter Pylori. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:
- Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases. 2021 Sep 23;9(4):66. [Accessed 26 Mar. 2024]. Available from:
- Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018 Jan;102(1):1-7. [Accessed 26 Mar. 2024]. Available from:
- Yu JH, Zhao Y, Wang XF, Xu YC. Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations. Diagnostics (Basel). 2022 May 12;12(5):1214. [Accessed 26 Mar. 2024]. Available from:
- She RC, Wilson AR, Litwin CM. Evaluation of Helicobacter pylori Immunoglobulin G (IgG), IgA, and IgM serologic testing compared to stool antigen testing. Clin Vaccine Immunol. 2009 Aug;16(8):1253-5. [Accessed 26 Mar. 2024]. Available from:
- Locatelli A, Catapani WR, Gomes CR Jr, Silva CB, Waisberg J. Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease. World J Gastroenterol. 2004 Oct 15;10(20):2997-3000. [Accessed 26 Mar. 2024]. Available from:
- Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions. World J Gastroenterol. 2003 Apr;9(4):755-8. [Accessed 26 Mar. 2024]. Available from:
Other tests
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)














